Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03503305 · ClinicalTrials.gov registry record · NA

Healing Osteoarthritic Joints in the Wrist With Adult ADRCs

A NA study of Osteoarthritis of the Wrist, sponsored by InGeneron.

Active
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT03503305 is a NA study of Osteoarthritis of the Wrist that is active but no longer recruiting, run by InGeneron. The registered enrollment target is 40 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03503305, a NA study of Osteoarthritis of the Wrist, is active but no longer recruiting, sponsored by InGeneron.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

This is a prospective, randomized, double-blinded, active controlled, single site safety and efficacy study in subjects suffering from chronic wrist osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the wrist.

Interventions

  • DRUG Corticosteroid injection
  • DEVICE adipose-derived stem cell injection

Study Locations (2)

South Dakota

  • Sanford USD Medical Center - Sioux Falls

Texas

  • HD Research - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-11-21
Est. Completion 2026-08
Phase NA

Sponsor

InGeneron

5 total trials

What the Registry Record Tells You About NCT03503305

The ClinicalTrials.gov registry entry for NCT03503305 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InGeneron, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis of the Wrist appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid injection is the first listed.

NCT03503305 reports 2 study locations spanning 2 distinct geographic areas - top geographies include South Dakota, Texas.

Frequently Asked Questions

What is clinical trial NCT03503305 about?

NCT03503305 is a clinical study titled "Healing Osteoarthritic Joints in the Wrist With Adult ADRCs". This is a prospective, randomized, double-blinded, active controlled, single site safety and efficacy study in subjects suffering from chronic wrist osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the wrist.

What is the current status of trial NCT03503305?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-11-21. Estimated completion is 2026-08.

What conditions does trial NCT03503305 study?

This clinical trial studies the following conditions: Osteoarthritis of the Wrist.

What interventions are being tested in trial NCT03503305?

The interventions under investigation include: Corticosteroid injection (DRUG), adipose-derived stem cell injection (DEVICE).

Who is sponsoring clinical trial NCT03503305?

This trial is sponsored by InGeneron, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03503305 being conducted?

This trial has 2 study locations across South Dakota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.